Allosteric communication in class A β-lactamases occurs via cooperative coupling of loop dynamics

  1. Ioannis Galdadas  Is a corresponding author
  2. Shen Qu
  3. Ana Sofia F Oliveira
  4. Edgar Olehnovics
  5. Andrew R Mack
  6. Maria F Mojica
  7. Pratul K Agarwal
  8. Catherine L Tooke
  9. Francesco Luigi Gervasio
  10. James Spencer
  11. Robert A Bonomo
  12. Adrian J Mulholland  Is a corresponding author
  13. Shozeb Haider  Is a corresponding author
  1. University College London, United Kingdom
  2. University of Bristol, United Kingdom
  3. Case Western Reserve University, United States
  4. Oklahoma State University, United States

Abstract

Understanding allostery in enzymes and tools to identify it, offer promising alternative strategies to inhibitor development. Through a combination of equilibrium and nonequilibrium molecular dynamics simulations, we identify allosteric effects and communication pathways in two prototypical class A β-lactamases, TEM-1 and KPC-2, which are important determinants of antibiotic resistance. The nonequilibrium simulations reveal pathways of communication operating over distances of 30 Å or more. Propagation of the signal occurs through cooperative coupling of loop dynamics. Notably, 50% or more of clinically relevant amino acid substitutions map onto the identified signal transduction pathways. This suggests that clinically important variation may affect, or be driven by, differences in allosteric behavior, providing a mechanism by which amino acid substitutions may affect the relationship between spectrum of activity, catalytic turnover and potential allosteric behavior in this clinically important enzyme family. Simulations of the type presented here will help in identifying and analyzing such differences.

Data availability

All analysis scripts have been uploaded on figshare with doi 10.6084/m9.figshare.13583384

Article and author information

Author details

  1. Ioannis Galdadas

    Chemistry ; Structural and Molecular Biology, University College London, London, United Kingdom
    For correspondence
    igaldadas@gmail.com
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2136-9723
  2. Shen Qu

    School of Pharmacy, University College London, London, United Kingdom
    Competing interests
    No competing interests declared.
  3. Ana Sofia F Oliveira

    School of Chemistry, University of Bristol, Bristol, United Kingdom
    Competing interests
    No competing interests declared.
  4. Edgar Olehnovics

    School of Pharmacy, University College London, London, United Kingdom
    Competing interests
    No competing interests declared.
  5. Andrew R Mack

    Department of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0131-7996
  6. Maria F Mojica

    Department of Infectious Diseases, Case Western Reserve University, Cleveland, United States
    Competing interests
    No competing interests declared.
  7. Pratul K Agarwal

    Department of Physiological Sciences and High-Performance Computing Center, Oklahoma State University, Stillwater, United States
    Competing interests
    Pratul K Agarwal, Pratul K Agarwal is the founder and owner of Arium BioLabs LLC..
  8. Catherine L Tooke

    School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
    Competing interests
    No competing interests declared.
  9. Francesco Luigi Gervasio

    Chemistry ; Structural and Molecular Biology, University College London, London, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4831-5039
  10. James Spencer

    School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
    Competing interests
    No competing interests declared.
  11. Robert A Bonomo

    Department of Infectious Diseases, Case Western Reserve University, Cleveland, United States
    Competing interests
    No competing interests declared.
  12. Adrian J Mulholland

    School of Chemistry, University of Bristol, Bristol, United Kingdom
    For correspondence
    adrian.mulholland@bristol.ac.uk
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1015-4567
  13. Shozeb Haider

    School of Pharmacy, University College London, London, United Kingdom
    For correspondence
    shozeb.haider@ucl.ac.uk
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2650-2925

Funding

AstraZeneca (Case Studentship)

  • Ioannis Galdadas

National Institute of Allergy and Infectious Diseases (R01AI072219)

  • Robert A Bonomo

National Institute of General Medical Sciences (GM105978)

  • Pratul K Agarwal

National Institutes of Health (RO1AI063517)

  • Robert A Bonomo
  • Shozeb Haider

Engineering and Physical Sciences Research Council (EP/M022609/1)

  • Ana Sofia F Oliveira
  • Adrian J Mulholland

Engineering and Physical Sciences Research Council (EP/N024117/1)

  • Ana Sofia F Oliveira
  • Adrian J Mulholland

Biotechnology and Biological Sciences Research Council (BB/L01386X/1)

  • Ana Sofia F Oliveira
  • Adrian J Mulholland

Medical Research Council (MR/T016035/1)

  • Catherine L Tooke
  • James Spencer
  • Adrian J Mulholland

National Institute of Allergy and Infectious Diseases (R01AI100560)

  • Robert A Bonomo

National Institute of Allergy and Infectious Diseases (R01AI063517)

  • Robert A Bonomo

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Galdadas et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,213
    views
  • 531
    downloads
  • 68
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ioannis Galdadas
  2. Shen Qu
  3. Ana Sofia F Oliveira
  4. Edgar Olehnovics
  5. Andrew R Mack
  6. Maria F Mojica
  7. Pratul K Agarwal
  8. Catherine L Tooke
  9. Francesco Luigi Gervasio
  10. James Spencer
  11. Robert A Bonomo
  12. Adrian J Mulholland
  13. Shozeb Haider
(2021)
Allosteric communication in class A β-lactamases occurs via cooperative coupling of loop dynamics
eLife 10:e66567.
https://doi.org/10.7554/eLife.66567

Share this article

https://doi.org/10.7554/eLife.66567

Further reading

    1. Medicine
    Gabriel O Heckerman, Eileen Tzng ... Adrienne Mueller
    Research Article

    Background: Several fields have described low reproducibility of scientific research and poor accessibility in research reporting practices. Although previous reports have investigated accessible reporting practices that lead to reproducible research in other fields, to date, no study has explored the extent of accessible and reproducible research practices in cardiovascular science literature.

    Methods: To study accessibility and reproducibility in cardiovascular research reporting, we screened 639 randomly selected articles published in 2019 in three top cardiovascular science publications: Circulation, the European Heart Journal, and the Journal of the American College of Cardiology (JACC). Of those 639 articles, 393 were empirical research articles. We screened each paper for accessible and reproducible research practices using a set of accessibility criteria including protocol, materials, data, and analysis script availability, as well as accessibility of the publication itself. We also quantified the consistency of open research practices within and across cardiovascular study types and journal formats.

    Results: We identified that fewer than 2% of cardiovascular research publications provide sufficient resources (materials, methods, data, and analysis scripts) to fully reproduce their studies. Of the 639 articles screened, 393 were empirical research studies for which reproducibility could be assessed using our protocol, as opposed to commentaries or reviews. After calculating an accessibility score as a measure of the extent to which an article makes its resources available, we also showed that the level of accessibility varies across study types with a score of 0.08 for Case Studies or Case Series and 0.39 for Clinical Trials (p = 5.500E-5) and across journals (0.19 through 0.34, p = 1.230E-2). We further showed that there are significant differences in which study types share which resources.

    Conclusion: Although the degree to which reproducible reporting practices are present in publications varies significantly across journals and study types, current cardiovascular science reports frequently do not provide sufficient materials, protocols, data, or analysis information to reproduce a study. In the future, having higher standards of accessibility mandated by either journals or funding bodies will help increase the reproducibility of cardiovascular research.

    Funding: Authors Gabriel Heckerman, Arely Campos-Melendez, and Chisomaga Ekwueme were supported by an NIH R25 grant from the National Heart, Lung and Blood Institute (R25HL147666). Eileen Tzng was supported by an AHA Institutional Training Award fellowship (18UFEL33960207).

    1. Cell Biology
    2. Medicine
    Pengbo Chen, Bo Li ... Xinfeng Zheng
    Research Article

    Background:

    It has been reported that loss of PCBP2 led to increased reactive oxygen species (ROS) production and accelerated cell aging. Knockdown of PCBP2 in HCT116 cells leads to significant downregulation of fibroblast growth factor 2 (FGF2). Here, we tried to elucidate the intrinsic factors and potential mechanisms of bone marrow mesenchymal stromal cells (BMSCs) aging from the interactions among PCBP2, ROS, and FGF2.

    Methods:

    Unlabeled quantitative proteomics were performed to show differentially expressed proteins in the replicative senescent human bone marrow mesenchymal stromal cells (RS-hBMSCs). ROS and FGF2 were detected in the loss-and-gain cell function experiments of PCBP2. The functional recovery experiments were performed to verify whether PCBP2 regulates cell function through ROS/FGF2-dependent ways.

    Results:

    PCBP2 expression was significantly lower in P10-hBMSCs. Knocking down the expression of PCBP2 inhibited the proliferation while accentuated the apoptosis and cell arrest of RS-hBMSCs. PCBP2 silence could increase the production of ROS. On the contrary, overexpression of PCBP2 increased the viability of both P3-hBMSCs and P10-hBMSCs significantly. Meanwhile, overexpression of PCBP2 led to significantly reduced expression of FGF2. Overexpression of FGF2 significantly offset the effect of PCBP2 overexpression in P10-hBMSCs, leading to decreased cell proliferation, increased apoptosis, and reduced G0/G1 phase ratio of the cells.

    Conclusions:

    This study initially elucidates that PCBP2 as an intrinsic aging factor regulates the replicative senescence of hBMSCs through the ROS-FGF2 signaling axis.

    Funding:

    This study was supported by the National Natural Science Foundation of China (82172474).